Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NRC HealthNRC -0.98%63 EBITDA Margin % is -3.09% as of Jun. 2026. GuruFocus rates NRC with a GF Score™ of 63/100 and a GF Value™ of $19.94 (Fairly Valued). The stock has 8 warning signs investors should review. Among 664 Healthcare Providers & Services companies, NRC Health ranks better than 66.57% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. NRC Health's EBITDA for the
three
months ended in Jun. 2026 was $-1.1 Mil. NRC Health's Revenue for the
three
months ended in Jun. 2026 was $35.4 Mil. Therefore, NRC Health's EBITDA margin for the quarter that ended in Jun. 2026 was -3.09%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
NRC Health EBITDA Margin % Related Terms
NRC Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for NRC Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NRC vs EVH, SOPH, WEAV: EBITDA Margin % Comparison
For the Health Information Services subindustry, NRC Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NRC Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NRC Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where NRC Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NRC Health (NRC) has a EBITDA Margin % of -3.09% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NRC Health and its competitors. Over the past decade, NRC Health's EBITDA Margin % has ranged from 16.73 to 38.30. According to the industry distribution chart, NRC Health ranks #222 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 33.4%.
Is NRC Health's EBITDA Margin % too high?
NRC Health's current EBITDA Margin % is -3.09%. Over the past 10 years, this metric has ranged from a low of 16.73 to a high of 38.30. Based on the distribution chart, NRC Health ranks #222 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, NRC Health has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NRC Health's EBITDA Margin % compare to EVH and SOPH?
According to the Healthcare Providers & Services industry distribution chart, NRC Health ranks #222 out of 664 companies for EBITDA Margin %. This puts NRC Health in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Historically, NRC Health's own EBITDA Margin % has ranged from 16.73 to 38.30 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NRC Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NRC Health's current EBITDA Margin % is -3.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NRC Health stock overvalued right now?
Based on GuruFocus' analysis, NRC Health (NRC) is currently considered Fairly Valued. The stock's GF Value™ is $19.94, compared to a current price of $21.20 — trading 6.3% above its estimated fair value. The current EBITDA Margin % is -3.09%. NRC Health's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NRC Health (NRC), the current EBITDA Margin % is -3.09% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NRC Health (NRC) Overvalued in 2026?
Based on GuruFocus' analysis, NRC Health stock appears to be overvalued.
The current stock price of $21.20 is trading 6.3% above its estimated GF Value™ of $19.94.
GuruFocus considers NRC Health to be Fairly Valued.
Key valuation signals for NRC:
EBITDA Margin %: -3.09%
GF Value™: $19.94 vs. price of $21.20 (6.3% above fair value)
No single metric tells the full story. See the NRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
63GF Score
Get the complete analysis for NRC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NRC has been successfully added to your 
